No Detail Found!

Comparison of intralesional 5-fluorouracil and intralesional triamcinolone acetonide in the treatment of localized vitiligo

Author(s)
Maryam Tahir Dermatology Department, Sheikh Zayed Medical College and Hospital,Rahim Yar Khan,Pakistan
Muhammad Khurram Shahzad Dermatology Department, Sheikh Zayed Medical College and Hospital,Rahim Yar Khan,Pakistan
Tahir Hassan Dermatology Department, Sheikh Zayed Medical College and Hospital,Rahim Yar Khan,Pakistan
Naima Aliya Dermatology Department, Sheikh Zayed Medical College and Hospital,Rahim Yar Khan,Pakistan
Nazia Hanif Dermatology Department, Sheikh Zayed Medical College and Hospital,Rahim Yar Khan,Pakistan
Asma Naz Dermatology Department, Sheikh Zayed Medical College and Hospital,Rahim Yar Khan,Pakistan
Muhammad Irfan Jamil Lahore General Hospital,Lahore,Pakistan
Abstract
The objective of this study was to compare the efficacy and safety of intralesional 5-fluorouracil (5-FU) and triamcinolone acetonide (TA) in the treatment of localized vitiligo. the A non-randomized control trial conducted at Sheikh Zayed Hospital, RYK, from January to June 2022 included sixty patients, aged 18-60 years, with stable vitiligo. Patients were divided into two groups: Group A received 5-FU and Group B received TA. The outcome was assessed using the Vitiligo Area Scoring Index (VASI). There were 58.3% male and 41.7% female, with an average age of 33.33±11.24 years. Baseline characteristics between the two treatment groups were comparable. At 12 weeks, treatment responses were classified as excellent (16.6%), good (16.6%), moderate (35%) and poor (31.6%), with no significant intergroup differences (p=0.203). The 5-FU group showed a more significant lesion size reduction (1.28±1.09cm²) than the TA group (0.61±1.21 cm²) (p=0.028). Adverse effects mainly included pain and erythema. Common side effects included pain and erythema. The study concludes that both intralesional 5-FU and TA are effective and safe for treating localized vitiligo, with 5-FU potentially being more efficacious in lesion size reduction and promoting repigmentation.
Publication Details
Page(s) 1831-1836
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S6, Year: 2023

Request the full text from PASTIC

Keywords
efficacy, Vitiligo, Adverse events, intralesional triamcinolone acetonide, Intralesional 5-florouracil, localized vitiligo
0

Citations

0

Downloads

225

Views